We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£133.99
This is the most expensive it has ever been. Walk away.
£134 today · previous high £134 · all-time low £123
Elsevier Immuno-oncology and Immunotherapy Part C - Volume 191
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 64 days · 64 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 64 days • 2 price levels
Price Analysis
Most common price: £123 (60 days, 93.8%)
Price range: £123 - £134
Price levels: 2 different prices over 64 days
Description
Key Features
Volume 191 covers extraction, quantification and characterisation of histones, phosphatidylserine-targeting antibodies, and other key immuno-oncology methodologies.
Methods in Cell Biology series provides established protocols for ILC differentiation from HSCs in vitro and human Treg cell expansion with functional assays.
Features multicolour flow cytometry techniques for monitoring rapid activation of human gamma/delta T cells in immunotherapy research.
Published by Academic Press as part of a trusted series for cell biology and immunology professionals conducting cancer immunotherapy research.
Offers comprehensive chapters on both biochemical applications and therapeutic development within immuno-oncology and immunotherapy contexts.
Product Specifications
- Brand
- Elsevier
- Format
- hardcover
- ASIN
- 0443296200
- Domain
- Amazon UK
- Release Date
- 15 January 2025
- Listed Since
- 09 October 2024
Barcode
No barcode data available
Similar Products You Might Like
Academic Press Immuno-oncology and Immunotherapy Vol 190
Elsevier
Immuno-oncology and Immunotherapy Part A - Volume 189
Elsevier
Immuno-oncology and Immunotherapy Part D - Volume 196
Elsevier
Immuno-oncology and Immunotherapy Part F: Volume 201 (Methods in Cell Biology, Volume 201)
Elsevier
Immuno-oncology and Immunotherapy Part E - Volume 199
Elsevier
Academic Press Cell-based Cancer Immunotherapy Vol 183
Elsevier
Cancer Immunotherapy (Volume 209) (Progress in Molecular Biology and Translational Science, Volume 209)
Elsevier
Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies: 183 (Cancer Treatment and Research, 183)
Springer
Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies: 183 (Cancer Treatment and Research, 183)
Springer
The Microbiome in Cancer and Autoimmunity - Part B: Volume 395 (International Review of Cell and Molecular Biology, Volume 395)
Elsevier
Cancer Immunotherapy: Methods and Protocols: 2748 (Methods in Molecular Biology, 2748)
Humana
Cellular Therapy for Autoimmune Disease (Developments in Immunology)
Elsevier
Frontiers in Cancer Immunology; Systems Biology in Cancer Immunotherapy: 2
Bentham Science Publishers
T Cell Cancer Immunotherapy - Clinical Translation Guide
Elsevier
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
Springer
Principles of Immunotherapy in Breast and Gastrointestinal Cancers: Activity, Mechanisms of Resistance and New Sensitization Strategies (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)
Elsevier
Advanced Cancer Research Protocols Volume 198 - Methods in Cell Biology
Elsevier
The Microbiome in Cancer and Autoimmunity - Part A: Volume 394 (International Review of Cell and Molecular Biology, Volume 394)
Elsevier
Advances in Cancer Immunotherapy
IntechOpen
Targeting Signaling Pathways in Solid Tumors Part A: Volume 385 (International Review of Cell and Molecular Biology, Volume 385)
Elsevier
Evolution of Immunotherapy Against Tumors - Academic Press
Elsevier
Advances in DNA and mRNA Cancer Immunotherapy - Volume 165
Elsevier
Immuno-Oncology Crosstalk and Metabolism
Springer
